+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Soft Mist Inhaler"

Inhalable Drugs Market Report 2025 - Product Thumbnail Image

Inhalable Drugs Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
Metered Dose Inhaler Devices Market Report 2025 - Product Thumbnail Image

Metered Dose Inhaler Devices Market Report 2025

  • Report
  • April 2025
  • 175 Pages
  • Global
From
Aerosol Delivery Devices Market Report 2025 - Product Thumbnail Image

Aerosol Delivery Devices Market Report 2025

  • Report
  • April 2025
  • 200 Pages
  • Global
From
From
From
From
Smart Inhalers Market - Product Thumbnail Image

Smart Inhalers Market

  • Report
  • October 2025
  • 87 Pages
  • Global
From
Respiratory Inhalers Market Report 2023-2033 - Product Thumbnail Image

Respiratory Inhalers Market Report 2023-2033

  • Report
  • December 2022
  • 354 Pages
  • Global
From
Respiratory Inhalers Market - Global Outlook and Forecast 2020-2025 - Product Thumbnail Image

Respiratory Inhalers Market - Global Outlook and Forecast 2020-2025

  • Report
  • September 2020
  • 219 Pages
  • Global
From
From
From
From
From
From
From
Respiratory Inhalers Market Report and Forecast 2024-2032 - Product Thumbnail Image

Respiratory Inhalers Market Report and Forecast 2024-2032

  • Report
  • April 2024
  • 140 Pages
  • Global
From
Loading Indicator

The Soft Mist Inhaler (SMI) is a type of inhaler used to deliver medication to the lungs. It is a breath-activated device that produces a fine mist of medication, which is then inhaled by the patient. SMIs are used to treat a variety of respiratory conditions, including asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. They are also used to deliver medications for other conditions, such as allergies and COPD. SMIs are becoming increasingly popular due to their convenience and ease of use. They are also more cost-effective than other inhalers and nebulisers, making them a viable option for many patients. SMIs are also more discreet than other inhalers, making them a preferred choice for those who need to take their medication in public. The SMI market is highly competitive, with a number of companies offering a range of products. These include GlaxoSmithKline, Boehringer Ingelheim, Novartis, Merck, and AstraZeneca. Other companies in the market include 3M, Philips, and Teva Pharmaceuticals. Show Less Read more